Hennion & Walsh Asset Management, Inc. Emergent Bio Solutions Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$27.42 - $43.63 $12,668 - $20,157	-462 Reduced 2.48%	18,196 $565,000
Q1 2022 Apr 26, 2022	SELL	$36.48 - $52.22 $560,916 - $802,934	-15,376 Reduced 45.18%	18,658 $766,000
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $611,707 - $1.02 Million	-18,475 Reduced 35.18%	34,034 $1.48 Million
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $25,535 - $33,685	-510 Reduced 0.96%	52,509 $2.63 Million
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $751,497 - $1.07 Million	-13,275 Reduced 20.02%	53,019 $3.34 Million
Q1 2021 May 17, 2021	BUY	$86.23 - $125.19 $5.72 Million - $8.3 Million	66,294 New	66,294 $6.16 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.